Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4609]

FDA approves daratumumab and hyaluronidase-fihj with pomalidomide and dexamethasone for multiple myeloma

FDA approves daratumumab and hyaluronidase-fihj with pomalidomide and dexamethasone for multiple myeloma

Study sheds light on precise personalised hepatocellular carcinoma medicine

Study sheds light on precise personalised hepatocellular carcinoma medicine

Protein appears to prevent tumour cells from spreading via blood vessels

Protein appears to prevent tumour cells from spreading via blood vessels

FDA grants regular approval to enfortumab vedotin-ejfv for locally advanced or metastatic urothelial cancer

FDA grants regular approval to enfortumab vedotin-ejfv for locally advanced or metastatic urothelial cancer

EAU 2021: New use of old drug reduces risk of kidney cancer returning

EAU 2021: New use of old drug reduces risk of kidney cancer returning

Potential marker for success of immunotherapy in the treatment of lung cancer

Potential marker for success of immunotherapy in the treatment of lung cancer

EAU 2021: Nicotine by-product can predict recurrence of cancer

EAU 2021: Nicotine by-product can predict recurrence of cancer

New model aims to promote better-adapted bladder cancer treatment in the future

New model aims to promote better-adapted bladder cancer treatment in the future

Anti-androgen therapy can fuel spread of bone tumours in advanced prostate cancer

Anti-androgen therapy can fuel spread of bone tumours in advanced prostate cancer

New generation anti-cancer drug shows promise for children with brain tumours

New generation anti-cancer drug shows promise for children with brain tumours

More from ecancer